Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 2021

View Archived Issues

Novel series of 5,5-fused bicyclic PRMT5 inhibitors as potential anticancer therapeutics

Phase II results of suvratoxumab to prevent S. aureus ventilator-associated pneumonia

C4 selects CFT-8919 for progression into IND-enabling studies

The University of Pennsylvania describes fibronectin-targeting chimeric antigen receptors

AXL oncogene inhibitors discovered at Jiangsu Chia Tai Tianqing Pharmaceutical Group

Dual GLP-1/GCGR agonists synthesized at Dongguan Hec Biological Medicine Research & Development

Oncobix divulges mutant ALK/mutant EGFR inhibitors

REVOLUTION Medicines patents RAS inhibitors

Beclin-1 implicated in diabetic cardiomyopathy

FDA accepts IND application for LY-3819469

Oncorus announces development plans for its novel synthetic vRNA immunotherapy candidates

Gene signature governs anti-plaque microglia in AD

China NMPA approves CTA for phase IIb trial of AM-006 in Parkinson's disease

Activation of MT2 reduces cardiac I/R injury in prediabetic rats

Topical bevacizumab-800CW is safe for detecting esophageal lesions during NIR-FME

OSE's COVID-19 vaccine CoVepiT enters first-in-human study

DSMB recommends continuation of uniQure's phase I/II trial of AMT-130 in Huntington's disease

New biomarkers found to monitor disease progression in eosinophilic esophagitis

Preclinical data show AdCOVID neutralizes SARS-CoV-2 B.1.351 variant

Cystic Fibrosis Foundation awards support research at Metagenomi and Eloxx

AGT103-T HIV therapeutic enters first-in-human study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...